ALS

New Faculty Spotlight: Sali Farhan

23 Feb 2021

Sali Farhan is an accomplished human genomicist who bridges the gap between the clinic and the lab.

Multiple ALS projects at The Neuro awarded funding

Published: 15Feb2021

Program brings together multidisciplinary teams with expertise in various areas of neurodegenerative disease...

Year in Review 2020

23 Dec 2020

The major highlights from The Neuro during this unprecedented year

The MNI forms promising Open Science partnership with Takeda

Published: 4Dec2017

Industry and academia team up for the benefit of people suffering from ALS...

ALS care and research in a time of COVID-19

18 Jun 2020

Despite the COVID-19 pandemic, ALS patient care and research carries on at The Neuro with drug trials, a redesigned clinic, and a new approach for patients to maintain quality of life through...

Busy week for ALS research and awareness

Published: 13Sep2017

Research symposium, public education event and ALS walk planned...

A brighter future for ALS patients

1 May 2020

The first drug to be given Health Canada approval for amyotrophic lateral sclerosis (ALS) in more than two decades is now covered by Quebec public health insurance, a major victory for ALS patients...

Major ALS Research Funding Announced

Published: 23Nov2016

MNI scientists will study stem cells, genetic mutations to develop new treatments...

The Neuro to create world’s first ALS Phase 1 clinical trial unit

Published: 3Jul2017

The Tenaquip Foundation donation will allow for faster drug development, better care for ALS patients...

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam logo

 

The Neuro is a McGill research and teaching institute; delivering high quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

FacebookinstagramtwitterlinkedInyoutube

Back to top